8 results
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications Summary ... Table Insulin ... - Strong Medicine ... #medications #table ... endocrinology #dm2
Acute Pulmonary Embolism - Management Algorithms
 - Hemodynamically Stable Patients
 - Hemodynamically Unstable Patients

- Dr. Eric
Acute Pulmonary ... Embolism - Management Algorithms ... Hemodynamically Stable ... Eric Strong @DrEricStrong ... - Strong Medicine
Summary of All RCTs to Date on Endovascular Therapy for Acute Ischemic Stroke 

#EBM #Neurology #NeuroInterventionalRadiology
Summary of All RCTs ... Endovascular Therapy for Acute ... Ischemic Stroke ... #CVA #RCT #Summary ... #Table
Antiplatelet Medications - Summary Table

Aspirin - Inhibits cyclooxygenase, preventing formation of thromboxane A2
 • Acute coronary
Medications - Summary ... Table Aspirin ... stroke • Primary ... #Medications #Summary ... #Table #Pharmacology
DPP-4 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
- Pharmacology Summary ... Eric Strong @DrEricStrong ... - Strong Medicine ... #Pharmacology #Summary ... #DM2 #diabetes
Summary of Coagulation Deficiencies
Inherited:
 • Hemophilia A - Deficiency of Factor VIII
 • Hemophilia B -
Summary of Coagulation ... Post-partum • Acute ... catastrophes, Acute ... - Strong Medicine ... #table #comparison
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
- Pharmacology Summary ... Ozempic), or daily tablet ... - Strong Medicine ... #Pharmacology #Summary ... #DM2 #diabetes
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
metabolic equivalent able ... Insulin dependent DM ... event, follow ACC algorithm ... Stable patients ... • <6mo since stroke